spacer
home > ebr > spring 2017 > a complex system
PUBLICATIONS
European Biopharmaceutical Review

A Complex System

The concept of complex adaptive systems has a long history of use in describing and analysing the behaviour of biological systems across multiple different scales from collective animal behaviour to the emergence of cellular function from the interaction of large collections of molecules. The key characteristics of any complex adaptive system are that the behaviour of the system emerges due to the interactions between multiple typically much simpler entities, and that the behaviour of the system cannot be predicted by linear combinations of the isolated behaviour of the individual elements.

In addition, these systems adapt to changes in both the environment and underlying elements. Complex system theory aims to provide a framework in which non-linear behaviour can be understood and predicted. When applied to biological systems, and considered in the context of natural selection, these properties are thought to give rise to system resilience, robustness and evolvability (1,2).

Consideration of the cell as a complex system has consequences for drug discovery. Cellular function, including disease, arises due to interactions between proteins, secondmessengers and intrinsic small molecules within the cell (3). Cellular mechanisms of disease can be considered as a collection of pathological interactions that only occur in that disease state (4). This view of disease mechanism has found multiple recent applications including the hallmarks of cancer, immuno-oncology, cardiovascular disease and more.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jonny Wray is currently Head of Discovery Informatics at e-Therapeutics and has led the conceptual development of the networkdriven discovery approach and the design of the software platform embodying that method. He was a Fellow in Theoretical Neuroscience at The Neurosciences Institute, US, where his research was aimed at understanding how system function arises from network structure.
spacer
Jonny Wray
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables


More info >>

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>

 
Industry Events

Clinical Trial Supply Logistics & Temperature Management Forum

22-24 May 2017, Hotel Del Coronado| San Diego, CA

Ensuring timely distribution and formulating key forecasting methods to avoid clinical trial disruptions. We have gathered the sharpest minds from Eli Lilly, Sunovion Pharmaceuticals, Anthera, Genentech, and many more to optimize inventory processes, package and labeling, multi-vendor management, and new forecasting ideas that demonstrate safety, efficacy, and dosage in your clinical trial supply chain at the: Clinical Trial Supply Logistics & Temperature Management Forum
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement